Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00824707
What this trial is testing

Efficacy and Significance of Antiviral Therapy for Unresectable Hepatitis B Virus-related Primary Liver Cancer

Who this might be right for
Primary Liver Cancer
Eastern Hepatobiliary Surgery Hospital 200
Testing effectiveness (Phase 2)Ended earlyNCT00983541
What this trial is testing

Chemoradiation +Gemcitabine +Continuous 5-FU (Fluorouracil) Followed by High Dose Brachytherapy/Stereotactic Radiation Boost in Locally Advanced Intra/Extrahepatic Cholangiocarcinoma

Who this might be right for
Cancer
University of Utah 1
Post-approval studies (Phase 4)Not Yet RecruitingNCT06786429
What this trial is testing

Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.

Who this might be right for
Hepatitis BHuman Papilloma VirusMental Health Issue+3 more
Eunice Dube 2,140
Testing effectiveness (Phase 2)Ended earlyNCT05448677
What this trial is testing

Ezurpimtrostat Autophagy Inhibitor in Association With Atezolizumab-Bevacizumab in First Line Treatment of Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
University Hospital, Grenoble 3
Very early researchUnknownNCT05886075
What this trial is testing

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors

Who this might be right for
Lung CancerBronchial CancerNon Small Cell Lung Cancer+9 more
Shanghai Yunying Medical Technology 24
Post-approval studies (Phase 4)UnknownNCT02308319
What this trial is testing

Prompt Or Watchful Monitoring for Hepatitis B Virus Related Hepatocellular Carcinoma Without Elevated viRal Load

Who this might be right for
Carcinoma, Hepatocellular
Samsung Medical Center 124
Not applicableStudy completedNCT03717519
What this trial is testing

Elevated Platelet Count as Prognostic Factor in Colorectal Cancer With Synchronous Liver Metastases

Who this might be right for
Colorectal CancerColorectal CarcinomaStage IV Colon Cancer
Azienda Ospedaliera Universitaria Integrata Verona 196
Not applicableStudy completedNCT02173119
What this trial is testing

Can Quantitative MRI After cTACE Help Predict Survival ?

Who this might be right for
Hepatocellular Carcinoma (HCC)
Medical College of Wisconsin 23
Not applicableStudy completedNCT00178867
What this trial is testing

A National Registry of Patients With Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Vanderbilt University 150
Testing effectiveness (Phase 2)Looking for participantsNCT06015022
What this trial is testing

EGCG for Hepatocellular Carcinoma Chemoprevention

Who this might be right for
Cirrhosis, Liver
University of Texas Southwestern Medical Center 60
Not applicableUnknownNCT03206866
What this trial is testing

Role of Serum Regucalcin in Diagnosis of Hepatocellular Carcinoma

Who this might be right for
Role of Serum Regucalcin in Diagnosis of HCC
Mansoura University 96
Not applicableStudy completedNCT04966195
What this trial is testing

Stereotactic Body Radiotherapy Based Treatment for Hepatocellular Carcinoma With Extensive Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular Carcinoma Non-resectablePortal Vein Tumor ThrombosisStereotactic Body Radiotherapy
Second Affiliated Hospital, Zhejiang University, School of Medicine 100
Not applicableActive Not RecruitingNCT07048665
What this trial is testing

Effectiveness of Trans-Arterial Chemo Embolization for Hepatocellular Carcinoma on Follow-Up CT Triphasic Liver

Who this might be right for
Hepatocellular Carcinoma
Superior University 60
Large-scale testing (Phase 3)WithdrawnNCT01318200
What this trial is testing

Transarterial Chemoembolization (TACE) vs. CyberKnife for Recurrent Hepatocellular Carcinoma (HCC)

Who this might be right for
Recurrent Hepatocellular Carcinoma
Accuray Incorporated
Early research (Phase 1)WithdrawnNCT07365839
What this trial is testing

Cemiplimab +/- Fianlimab Post Y90 Radioembolization in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Virginia Commonwealth University
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06935175
What this trial is testing

SHR-1826 Monotherapy or in Combination With Immunotherapy in the Treatment of Advanced Hepatocellular Cancer

Who this might be right for
Hepatocellular Cancer
Shanghai Zhongshan Hospital 53
Large-scale testing (Phase 3)Not Yet RecruitingNCT07309419
What this trial is testing

A Phase III Randomized Study of TACE Plus an Oral Triple-Agent Cocktail Versus TACE Plus First-Line Targeted Immunotherapy in Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Shanghai Zhongshan Hospital 222
Testing effectiveness (Phase 2)Study completedNCT03535259
What this trial is testing

Phase II Study of Concurrent Sorafenib and Intensity-modulated Radiotherapy (IMRT) for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma, Radiotherapy, Sorafenib
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 86
Not applicableStudy completedNCT04975932
What this trial is testing

Efficacy and Safety of TACE in Combination With ICIs for HCC: a Real-world Study

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 826
Testing effectiveness (Phase 2)Study completedNCT00058487
What this trial is testing

Epirubicin and Thalidomide in Treating Patients With Liver Cancer

Who this might be right for
Liver Cancer
Dana-Farber Cancer Institute 12
Next Page